Diane Carlisle

Scientific Consultant for Huntington's Disease Preclinical Development at NeuBase Therapeutics - Pittsburgh, PA, US

Diane Carlisle's Contact Details
HQ
N/A
Location
Pittsburgh,Pennsylvania,United States
Company
NeuBase Therapeutics
Diane Carlisle's Company Details
NeuBase Therapeutics logo, NeuBase Therapeutics contact details

NeuBase Therapeutics

Pittsburgh, PA, US • 50 - 99 Employees
Major Drugs

NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase's pipeline includes therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington's disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been "undruggable."

Biotechnology Gene Silencing Antisense Oligonucleotide Therapies Rare Disease Genetic Disease Huntington's Disease Myotonic Dystrophy CNS Disease Huntington's Disease
Details about NeuBase Therapeutics
Frequently Asked Questions about Diane Carlisle
Diane Carlisle currently works for NeuBase Therapeutics, Inc..
Diane Carlisle's role at NeuBase Therapeutics, Inc. is Scientific Consultant for Huntington's Disease Preclinical Development.
Diane Carlisle's email address is ***@neubasetherapeutics.com. To view Diane Carlisle's full email address, please signup to ConnectPlex.
Diane Carlisle works in the Pharmaceuticals industry.
Diane Carlisle's colleagues at NeuBase Therapeutics are Valentina Caro, Mykaela Wagner, Bridget Sawyer-Revels, Thomas Zengeya, Dani Stoltzfus, Barry Badeau, Ramesh Batwal and others.
Diane Carlisle's phone number is N/A
See more information about Diane Carlisle